Xiang-ran Yang

Learn More
The purpose of this study was to examine whether combined cisplatin and late course accelerated fractionation radiotherapy (LCAH) (the combined group) can confer a better outcome over LCAH alone in treating esophageal carcinoma. Eighty-one eligible patients were randomly entered into two groups: the LCAH alone group, and the combined group. There was a(More)
OBJECTIVE To investigate the association of single nucleotide polymorphism (SNP) of manganese superoxide dismutase (MnSOD) gene with carcinogenesis and progression of esophageal squamous cell carcinoma. METHODS The MnSOD9 T-->C SNP was genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis in 103 patients with(More)
OBJECTIVE To investigate the expression of manganese superoxide dismutase (MnSOD) and to determine the relationship between MnSOD expression and clinicopathological features, biological behaviors in esophageal carcinoma. METHODS Immunohistochemistry (SP) and RT-PCR were respectively used to detect the expression of MnSOD in 45 specimens of esophageal(More)
The aim of the present study was to investigate the efficacy and side‐effects of preventive treatment with pegylated recombinant human granulocyte colony‐stimulating factor (PEG‐rhG‐CSF) on concurrent chemoradiotherapy‐induced grade IV neutropenia and to provide a rational basis for its clinical application. A total of 114 patients with concurrent(More)
  • 1